Brivanib抑制劑Brivanib is an ATP-competitive inhibitor against VEGFR2 with IC50 of 25 nM, moderate potency against VEGFR-1 and FGFR-1, but >240-fold against PDGFR-β. Phase 3.
| 產(chǎn)品名稱： | Brivanib | ||
| 英文名： | Brivanib | ||
| CAS NO.： | 649735-46-6 | ||
| 分子式： | C19H19FN4O3 | ||
| 分子量： | 370.377567529678 | ||
| 產(chǎn)品品牌： | targetmol | ||
| 產(chǎn)品規(guī)格： | 1mg | ||
